• Citer

Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome: Study protocol for a randomized controlled trial

par Bellingan, Geoff;Jalkanen, Markku;Piippo, Ilse;Ranieri, Vito Marco;Brealey, David;Mancebo, Jordi;Mercat, Alain;Patroniti, Nicolò;Pettila, Ville;Quintel, Michael;Vincent, Jean Louis ;Maksimow, Mikael
Référence Trials, 18, 1, 536
Publication Publié, 2017-11

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome: Study protocol for a randomized controlled trial
Auteur:	Bellingan, Geoff; Jalkanen, Markku; Piippo, Ilse; Ranieri, Vito Marco; Brealey, David; Mancebo, Jordi; Mercat, Alain; Patroniti, Nicolò; Pettila, Ville; Quintel, Michael; Vincent, Jean Louis; Maksimow, Mikael
Informations sur la publication:	Trials, 18, 1, 536
Statut de publication:	Publié, 2017-11
Sujet CREF:	Sciences bio-médicales et agricoles
	Pharmacologie
Mots-clés:	ARDS
	CD73
	Interferon
	Vascular leakage
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1745-6215
	info:doi/10.1186/s13063-017-2234-7
	info:scp/85033781066